Cargando…

Coronavirus Immunotherapeutic Consortium Database

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has seen multiple anti-SARS-CoV-2 antibodies being generated globally. It is difficult, however, to assemble a useful compendium of these biological properties if they are deri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahita, Jarjapu, Ha, Brendan, Gambiez, Anais, Schendel, Sharon L, Li, Haoyang, Hastie, Kathryn M, Dennison, S Moses, Li, Kan, Kuzmina, Natalia, Periasamy, Sivakumar, Bukreyev, Alexander, Munt, Jennifer E, Osei-Twum, Mary, Atyeo, Caroline, Overton, James A, Vita, Randi, Guzman-Orozco, Hector, Mendes, Marcus, Kojima, Mari, Halfmann, Peter J, Kawaoka, Yoshihiro, Alter, Galit, Gagnon, Luc, Baric, Ralph S, Tomaras, Georgia D, Germann, Tim, Bedinger, Daniel, Greenbaum, Jason A, Saphire, Erica Ollmann, Peters, Bjoern
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913043/ https://www.ncbi.nlm.nih.gov/pubmed/36763096 http://dx.doi.org/10.1093/database/baac112

Ejemplares similares

SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants
por: Li, Kan, et al.
Publicado: (2022)

Integrative modelling of TIR domain-containing adaptor molecule inducing interferon-β (TRIF) provides insights into its autoinhibited state
por: Mahita, Jarjapu, et al.
Publicado: (2017)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens
por: Marrama, Daniel, et al.
Publicado: (2022)

Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023)

Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses
por: Hastie, Kathryn M, et al.
Publicado: (2012)

Neutralizing Antibodies against Lassa Virus Lineage I
por: Buck, Tierra K., et al.
Publicado: (2022)

IEDB‐3D 2.0: Structural data analysis within the Immune Epitope Database
por: Mendes, Marcus, et al.
Publicado: (2023)

Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease
por: Hastie, Kathryn M., et al.
Publicado: (2012)

133 Structural basis for ebolavirus matrix assembly and budding; protein plasticity allows multiple functions
por: Bornholdt, Zachary, et al.
Publicado: (2014)

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses
por: Amanat, Fatima, et al.
Publicado: (2018)

IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
por: Chang, Matthew R., et al.
Publicado: (2022)

A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection
por: Malherbe, Delphine C., et al.
Publicado: (2022)

A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection
por: Ronk, Adam J., et al.
Publicado: (2023)

Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
por: Meyer, Michelle, et al.
Publicado: (2018)

Computational epitope binning reveals functional equivalence of sequence-divergent paratopes
por: Mahita, Jarjapu, et al.
Publicado: (2022)

Development and Structural Analysis of Antibody Therapeutics for Filoviruses
por: Yu, Xiaoying, et al.
Publicado: (2022)

Lifted Up from Lockdown
por: Arturo, Emilia C., et al.
Publicado: (2020)

Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism
por: Bale, Shridhar, et al.
Publicado: (2012)

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
por: Atyeo, Caroline, et al.
Publicado: (2021)

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
por: Bowman, Kathryn A., et al.
Publicado: (2022)

Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication
por: Fang, Jingru, et al.
Publicado: (2022)

Plasmodium infection disrupts the T follicular helper cell response to heterologous immunization
por: Fontana, Mary F, et al.
Publicado: (2023)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
por: Alter, Galit, et al.
Publicado: (2021)

Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies
por: Enriquez, Adrian S., et al.
Publicado: (2022)

A Shared Structural Solution for Neutralizing Ebolaviruses
por: Dias, João M., et al.
Publicado: (2011)

Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
por: Ilinykh, Philipp A., et al.
Publicado: (2018)

Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals
por: Fang, Jingru, et al.
Publicado: (2022)

SnapShot: Enveloped Virus Entry
por: Mercer, Jason, et al.
Publicado: (2020)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M(™) vaccination
por: Gorman, Matthew J, et al.
Publicado: (2021)

HER2-mediated enhancement of Ebola virus entry
por: Kuroda, Makoto, et al.
Publicado: (2020)

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
por: King, Liam B., et al.
Publicado: (2019)

Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection
por: Malherbe, Delphine C., et al.
Publicado: (2020)

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022)

The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis
por: Kirchdoerfer, Robert N., et al.
Publicado: (2016)

CD164 is a host factor for lymphocytic choriomeningitis virus entry
por: Bakkers, Mark J. G., et al.
Publicado: (2022)

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
por: Gorman, Matthew J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hd6oqvh570ng6ejvlk7jb0au7s